Mark Exley
Chief Scientific Officer LIfT BioSciences Ltd
Seminars
Wednesday 16th September 2026
Panel Discussion: Highlighting Strategies to Streamline Regulatory Approval Across Regulatory Agencies
2:30 pm
- Detailing the transition process between FDA, EMA and IIT clinical programs to streamline clinical development across borders
- Discussing strategies for incorporating early clinical readouts from international studies to enable faster decision making before US trial initiation
- Evaluating evolving US regulatory comfort with globally generated data to showcase how aligned global development strategies can accelerate innovation while maintaining regulatory rigor
Wednesday 16th September 2026
IMANs as an Example of Innate Cells’ Direct & Indirect Therapeutic Activity
3:30 pm
- Demonstrating innate cell types including IMANs direct therapeutic activity
- Improving and broadening IMAN activity with CARs
- Showing IMANs help CAR-T, CAR-NK and other cell therapies work when they don’t
